Wall St. Cheat Sheet » Business Recaps »

Big Pharma Lines Up For Amarin: Healthcare Business Wrap

October 25, 2012

Merck & Co. (NYSE:MRK) is among a number of drug firms which “would love to get their hands” on Amarin Corporation (NASDAQ:AMRN) for Vascepa, says the Daily Mail, which also says that AstraZeneca (NYSE:AZN) could be readying a cash bid for the company as well. Other big pharma companies, such as Eli Lilly and Company (NYSE:LLY), Abbott Laboratories (NYSE:ABT) and Pfizer could get into the action.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About: Business Investing Markets Merck & Co NASDAQ:AMRN NYSE:ABT NYSE:AZN NYSE:LLY NYSE:MRK Stocks Trading

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com